434 related articles for article (PubMed ID: 36126994)
21. Enhanced CD25
Won HY; Shin JH; Oh S; Jeong H; Hwang ES
Sci Rep; 2017 Dec; 7(1):16946. PubMed ID: 29208963
[TBL] [Abstract][Full Text] [Related]
22. Increased prevalence of regulatory T cells (Treg) is induced by pancreas adenocarcinoma.
Liyanage UK; Goedegebuure PS; Moore TT; Viehl CT; Moo-Young TA; Larson JW; Frey DM; Ehlers JP; Eberlein TJ; Linehan DC
J Immunother; 2006; 29(4):416-24. PubMed ID: 16799337
[TBL] [Abstract][Full Text] [Related]
23. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
Chen W; Jin W; Hardegen N; Lei KJ; Li L; Marinos N; McGrady G; Wahl SM
J Exp Med; 2003 Dec; 198(12):1875-86. PubMed ID: 14676299
[TBL] [Abstract][Full Text] [Related]
24. Characterization of protective human CD4CD25 FOXP3 regulatory T cells generated with IL-2, TGF-β and retinoic acid.
Lu L; Zhou X; Wang J; Zheng SG; Horwitz DA
PLoS One; 2010 Dec; 5(12):e15150. PubMed ID: 21179414
[TBL] [Abstract][Full Text] [Related]
25. African Swine Fever Virus Armenia/07 Virulent Strain Controls Interferon Beta Production through the cGAS-STING Pathway.
García-Belmonte R; Pérez-Núñez D; Pittau M; Richt JA; Revilla Y
J Virol; 2019 Jun; 93(12):. PubMed ID: 30918080
[TBL] [Abstract][Full Text] [Related]
26. A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-beta.
Selvaraj RK; Geiger TL
J Immunol; 2007 Jun; 178(12):7667-77. PubMed ID: 17548603
[TBL] [Abstract][Full Text] [Related]
27. TNF-α impairs differentiation and function of TGF-β-induced Treg cells in autoimmune diseases through Akt and Smad3 signaling pathway.
Zhang Q; Cui F; Fang L; Hong J; Zheng B; Zhang JZ
J Mol Cell Biol; 2013 Apr; 5(2):85-98. PubMed ID: 23243069
[TBL] [Abstract][Full Text] [Related]
28. INFα-2b inhibitory effects on CD4(+)CD25(+)FOXP3(+) regulatory T cells in the tumor microenvironment of C57BL/6 J mice with melanoma xenografts.
Yu Y; Huang R; Zong X; He X; Mo W
BMC Cancer; 2016 Jul; 16():397. PubMed ID: 27389040
[TBL] [Abstract][Full Text] [Related]
29. Endogenous TGF-beta activation by reactive oxygen species is key to Foxp3 induction in TCR-stimulated and HIV-1-infected human CD4+CD25- T cells.
Amarnath S; Dong L; Li J; Wu Y; Chen W
Retrovirology; 2007 Aug; 4():57. PubMed ID: 17688698
[TBL] [Abstract][Full Text] [Related]
30. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
Pyzik M; Piccirillo CA
J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
[TBL] [Abstract][Full Text] [Related]
31. Tumor-derived TGF-beta mediates conversion of CD4+Foxp3+ regulatory T cells in a murine model of pancreas cancer.
Moo-Young TA; Larson JW; Belt BA; Tan MC; Hawkins WG; Eberlein TJ; Goedegebuure PS; Linehan DC
J Immunother; 2009 Jan; 32(1):12-21. PubMed ID: 19307989
[TBL] [Abstract][Full Text] [Related]
32. A Cellular MicroRNA Facilitates Regulatory T Lymphocyte Development by Targeting the
Zhang Y; Liu W; Chen Y; Liu J; Wu K; Su L; Zhang W; Jiang Y; Zhang X; Zhang Y; Liu C; Tao L; Liu B; Zhang H
J Immunol; 2018 Feb; 200(3):1053-1063. PubMed ID: 29282311
[TBL] [Abstract][Full Text] [Related]
33. Downstream STING pathways IRF3 and NF-κB differentially regulate CCL22 in response to cytosolic dsDNA.
Kim J; Pena JV; McQueen HP; Kong L; Michael D; Lomashvili EM; Cook PR
Cancer Gene Ther; 2024 Jan; 31(1):28-42. PubMed ID: 37990062
[TBL] [Abstract][Full Text] [Related]
34.
Lawless OJ; Bellanti JA; Brown ML; Sandberg K; Umans JG; Zhou L; Chen W; Wang J; Wang K; Zheng SG
Allergy Asthma Proc; 2018 Mar; 39(2):143-152. PubMed ID: 29490770
[TBL] [Abstract][Full Text] [Related]
35. Targeting the activin receptor 1C on CD4+ T cells for cancer immunotherapy.
Zheng Y; Lebid A; Chung L; Fu J; Wang X; Otrocol A; Zarif JC; Yu H; Llosa NJ; Pardoll DM
Oncoimmunology; 2024; 13(1):2297503. PubMed ID: 38235319
[TBL] [Abstract][Full Text] [Related]
36. Induced regulatory T cells are phenotypically unstable and do not protect mice from rapidly progressive glomerulonephritis.
Ghali JR; Alikhan MA; Holdsworth SR; Kitching AR
Immunology; 2017 Jan; 150(1):100-114. PubMed ID: 27606831
[TBL] [Abstract][Full Text] [Related]
37. Activation of STING inhibits cervical cancer tumor growth through enhancing the anti-tumor immune response.
Shi F; Su J; Wang J; Liu Z; Wang T
Mol Cell Biochem; 2021 Feb; 476(2):1015-1024. PubMed ID: 33141310
[TBL] [Abstract][Full Text] [Related]
38. MEK inhibition prevents tumour-shed transforming growth factor-β-induced T-regulatory cell augmentation in tumour milieu.
Hossain DM; Panda AK; Chakrabarty S; Bhattacharjee P; Kajal K; Mohanty S; Sarkar I; Sarkar DK; Kar SK; Sa G
Immunology; 2015 Apr; 144(4):561-73. PubMed ID: 25284464
[TBL] [Abstract][Full Text] [Related]
39. Dependence on nuclear factor of activated T-cells (NFAT) levels discriminates conventional T cells from Foxp3+ regulatory T cells.
Vaeth M; Schliesser U; Müller G; Reissig S; Satoh K; Tuettenberg A; Jonuleit H; Waisman A; Müller MR; Serfling E; Sawitzki BS; Berberich-Siebelt F
Proc Natl Acad Sci U S A; 2012 Oct; 109(40):16258-63. PubMed ID: 22991461
[TBL] [Abstract][Full Text] [Related]
40. CD71+VISTA+ erythroid cells promote the development and function of regulatory T cells through TGF-β.
Shahbaz S; Bozorgmehr N; Koleva P; Namdar A; Jovel J; Fava RA; Elahi S
PLoS Biol; 2018 Dec; 16(12):e2006649. PubMed ID: 30550561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
